Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Feldman

Showing results (1011-1020 of 1,068) with videos related to

Pageof 107
Sort By:
Lancet (London, England)|July 12, 2024
CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 studyMatthew J Frank, John H Baird, Anne Marijn Kramer, et al.
Blood|December 15, 2005
Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpuraCarolyn M Bennett, Zora R Rogers, Daniel D Kinnamon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2018
T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple MyelomaJennifer N Brudno, Irina Maric, Steven D Hartman, et al.
Pediatric Blood & Cancer|October 22, 2008
One year follow-up of children and adolescents with chronic immune thrombocytopenic purpura (ITP) treated with rituximabBrigitta U Mueller, Carolyn M Bennett, Henry A Feldman, et al.
Surgery|November 12, 2023
Implementation of a novel peer review academy by Surgery and the Association of Women SurgeonsM Libby Weaver, Laura M Drudi, Alexandra M Adams, et al.
Journal of Clinical and Translational Science|May 1, 2024
Strategies to promote language inclusion at 17 CTSA hubsLinda Sprague Martinez, Cristina Araujo Brinkerhoff, Riana C Howard, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 6, 2015
Clinical Scale Zinc Finger Nuclease-mediated Gene Editing of PD-1 in Tumor Infiltrating Lymphocytes for the Treatment of Metastatic MelanomaJoal D Beane, Gary Lee, Zhili Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2014
A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with responsePaul F Robbins, Sadik H Kassim, Thai L N Tran, et al.
Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
Propofol for treatment resistant depression: A randomized controlled trialScott C Tadler, Keith G Jones, Carter Lybbert, et al.
Scientific Reports|August 24, 2021
High-content image-based analysis and proteomic profiling identifies Tau phosphorylation inhibitors in a human iPSC-derived glutamatergic neuronal model of tauopathyChialin Cheng, Surya A Reis, Emily T Adams, et al.
Pageof 107

Showing results (1011-1020 of 1,068) with videos related to

Sort By:
Pageof 107
Lancet (London, England)|July 12, 2024
CD22-directed CAR T-cell therapy for large B-cell lymphomas progressing after CD19-directed CAR T-cell therapy: a dose-finding phase 1 studyMatthew J Frank, John H Baird, Anne Marijn Kramer, et al.
Blood|December 15, 2005
Prospective phase 1/2 study of rituximab in childhood and adolescent chronic immune thrombocytopenic purpuraCarolyn M Bennett, Zora R Rogers, Daniel D Kinnamon, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 30, 2018
T Cells Genetically Modified to Express an Anti-B-Cell Maturation Antigen Chimeric Antigen Receptor Cause Remissions of Poor-Prognosis Relapsed Multiple MyelomaJennifer N Brudno, Irina Maric, Steven D Hartman, et al.
Pediatric Blood & Cancer|October 22, 2008
One year follow-up of children and adolescents with chronic immune thrombocytopenic purpura (ITP) treated with rituximabBrigitta U Mueller, Carolyn M Bennett, Henry A Feldman, et al.
Surgery|November 12, 2023
Implementation of a novel peer review academy by Surgery and the Association of Women SurgeonsM Libby Weaver, Laura M Drudi, Alexandra M Adams, et al.
Journal of Clinical and Translational Science|May 1, 2024
Strategies to promote language inclusion at 17 CTSA hubsLinda Sprague Martinez, Cristina Araujo Brinkerhoff, Riana C Howard, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|May 6, 2015
Clinical Scale Zinc Finger Nuclease-mediated Gene Editing of PD-1 in Tumor Infiltrating Lymphocytes for the Treatment of Metastatic MelanomaJoal D Beane, Gary Lee, Zhili Zheng, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 25, 2014
A pilot trial using lymphocytes genetically engineered with an NY-ESO-1-reactive T-cell receptor: long-term follow-up and correlates with responsePaul F Robbins, Sadik H Kassim, Thai L N Tran, et al.
Medrxiv : the Preprint Server for Health Sciences|September 25, 2023
Propofol for treatment resistant depression: A randomized controlled trialScott C Tadler, Keith G Jones, Carter Lybbert, et al.
Scientific Reports|August 24, 2021
High-content image-based analysis and proteomic profiling identifies Tau phosphorylation inhibitors in a human iPSC-derived glutamatergic neuronal model of tauopathyChialin Cheng, Surya A Reis, Emily T Adams, et al.
Pageof 107